lipoxin a4 and Atherosclerosis

lipoxin a4 has been researched along with Atherosclerosis in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's3 (60.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Hao, H; Xu, F; Zhang, J; Zhou, X1
Ali-Shah, ST; Barry, M; Belton, O; Beuscart, O; Brennan, EP; Cooper, ME; Crean, D; Dai, A; de Gaetano, M; Derouiche, S; Dowdall, JF; Godson, C; Godson-Treacy, M; Gray, SP; Guiry, PJ; Jandeleit-Dahm, K; Kantharidis, P; Marai, M; McClelland, A; Mohan, M; Pickering, R; Sheehan, S; Tan, SM; Tikellis, C1
Arnardottir, H; Bäck, M; Hansson, GK; Laguna-Fernandez, A; Perretti, M; Petri, MH; Wheelock, CE1
Chan, L; Gotlinger, KH; Ko, K; Merched, AJ; Serhan, CN1
Bengtsson, T; Bergström, I; Börgeson, E; Brodin, VP; Lönn, J; Nayeri, F; Ramström, S; Särndahl, E1

Other Studies

5 other study(ies) available for lipoxin a4 and Atherosclerosis

ArticleYear
Lipoxin A
    Experimental cell research, 2022, 03-01, Volume: 412, Issue:1

    Topics: Animals; Atherosclerosis; Diet, High-Fat; Disease Models, Animal; Foam Cells; Heptanoic Acids; Humans; Kelch-Like ECH-Associated Protein 1; Lipoxins; Male; NF-E2-Related Factor 2; Oxidative Stress; Rats; Rats, Sprague-Dawley; Receptors, Lipoxin; Signal Transduction; THP-1 Cells

2022
Lipoxins Protect Against Inflammation in Diabetes-Associated Atherosclerosis.
    Diabetes, 2018, Volume: 67, Issue:12

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aorta; Atherosclerosis; Chemokine CCL2; Cytokines; Diabetes Mellitus, Experimental; Humans; Inflammation; Interleukin-1beta; Interleukin-6; Lipoxins; Mice; Vascular Cell Adhesion Molecule-1

2018
Aspirin-triggered lipoxin A4 inhibits atherosclerosis progression in apolipoprotein E
    British journal of pharmacology, 2017, Volume: 174, Issue:22

    Topics: Animals; Aorta; Apolipoproteins E; Aspirin; Atherosclerosis; Cytokines; Female; Lipoxins; Mice, Knockout; Receptors, Formyl Peptide

2017
Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2008, Volume: 22, Issue:10

    Topics: Animals; Apolipoproteins E; Arachidonate 12-Lipoxygenase; Arachidonate 15-Lipoxygenase; Atherosclerosis; Docosahexaenoic Acids; Endothelium, Vascular; Humans; Interleukins; Lipoxins; Macrophages; Mice; Mice, Knockout; Vasculitis

2008
Lipoxin A₄ inhibits porphyromonas gingivalis-induced aggregation and reactive oxygen species production by modulating neutrophil-platelet interaction and CD11b expression.
    Infection and immunity, 2011, Volume: 79, Issue:4

    Topics: Atherosclerosis; Bacteroidaceae Infections; Blood Platelets; Blotting, Western; CD11b Antigen; CD18 Antigens; Cell Aggregation; Cell Communication; Cell Separation; Flow Cytometry; Humans; Lipoxins; Microscopy, Fluorescence; Neutrophils; Porphyromonas gingivalis; Reactive Oxygen Species; rho GTP-Binding Proteins; Signal Transduction

2011